IL5 and allergic bronchopulmonary aspergillosis: In mucus-predominant allergic bronchopulmonary aspergillosis/ABPM with high FeNO/IgE levels after anti-IL-5 therapy, phenotype- and biomarker-guided sequencing of anti-TSLP antibodies may be considered.